CUE
NASDAQ
$33.46
Cue Biopharma Inc (CUE)
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biological drugs for the selective modulation of the human immune system to treat a variety of cancers, chronic infectious diseases, and autoimmune disorders. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $115 (+243.69%)
Market Cap
$93M
Revenue 5Y CAGR
+53.77%
Free Cash Flow Yield
-26.53%
Beta (5Y)
1.65
Price Chart
Valuation
Market Cap$93M
P/S3.66
P/B6.11
Profitability
Total Revenue (TTM)$33M
Gross Profit (TTM)-$862K
EBITDA-$18M
Profit Margin-91.1%
Operating Margin-94.1%
EPS-$7.31
Financial Health
Free Cash Flow Yield-26.53%
Growth & Risk
EPS 5Y CAGR-30.28%
Revenue 5Y CAGR+53.77%
FCF 5Y CAGR-6.58%
Beta (5Y)1.65
Sharpe Ratio0.84